Does Oruka Therapeutics, Inc. (ORKA) Have the Potential to Rally 41.51% as Wall Street Analysts Expect?

Shares of Oruka Therapeutics, Inc. (ORKA) have gained 29.6% over the past four weeks to close the last trading session at $41.75, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $59.08 indicates a potential upside of 41.5%.The average comprises 13 short-term price targets ranging from a low of $40.00 to a high of $75.00, with a standard deviation of $12.34. While the lowest esti ...